![Luminescence Enhancement after Adding Organic Salts to Nanohybrid under Aqueous Condition | ACS Applied Materials & Interfaces Luminescence Enhancement after Adding Organic Salts to Nanohybrid under Aqueous Condition | ACS Applied Materials & Interfaces](https://pubs.acs.org/cms/10.1021/am508265s/asset/images/medium/am-2014-08265s_0006.gif)
Luminescence Enhancement after Adding Organic Salts to Nanohybrid under Aqueous Condition | ACS Applied Materials & Interfaces
![IJMS | Free Full-Text | Molecular Pathogenesis and Peripheral Monitoring of Adult Fragile X-Associated Syndromes IJMS | Free Full-Text | Molecular Pathogenesis and Peripheral Monitoring of Adult Fragile X-Associated Syndromes](https://www.mdpi.com/ijms/ijms-22-08368/article_deploy/html/images/ijms-22-08368-g001.png)
IJMS | Free Full-Text | Molecular Pathogenesis and Peripheral Monitoring of Adult Fragile X-Associated Syndromes
![Ovarian Abnormalities in a Mouse Model of Fragile X Primary Ovarian Insufficiency - Gloria E. Hoffman, Wei Wei Le, Ali Entezam, Noriyuki Otsuka, Zhi-Bin Tong, Lawrence Nelson, Jodi A. Flaws, John H. Ovarian Abnormalities in a Mouse Model of Fragile X Primary Ovarian Insufficiency - Gloria E. Hoffman, Wei Wei Le, Ali Entezam, Noriyuki Otsuka, Zhi-Bin Tong, Lawrence Nelson, Jodi A. Flaws, John H.](https://journals.sagepub.com/cms/10.1369/0022155412441002/asset/images/large/10.1369_0022155412441002-fig13.jpeg)
Ovarian Abnormalities in a Mouse Model of Fragile X Primary Ovarian Insufficiency - Gloria E. Hoffman, Wei Wei Le, Ali Entezam, Noriyuki Otsuka, Zhi-Bin Tong, Lawrence Nelson, Jodi A. Flaws, John H.
![Transcriptional networks regulating neuronal identity in the developing spinal cord | Nature Neuroscience Transcriptional networks regulating neuronal identity in the developing spinal cord | Nature Neuroscience](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnn750/MediaObjects/41593_2001_Article_BFnn750_Fig1_HTML.gif)
Transcriptional networks regulating neuronal identity in the developing spinal cord | Nature Neuroscience
![Clocks & Sleep | Free Full-Text | MicroRNA: A Key Player for the Interplay of Circadian Rhythm Abnormalities, Sleep Disorders and Neurodegenerative Diseases Clocks & Sleep | Free Full-Text | MicroRNA: A Key Player for the Interplay of Circadian Rhythm Abnormalities, Sleep Disorders and Neurodegenerative Diseases](https://www.mdpi.com/clockssleep/clockssleep-02-00022/article_deploy/html/images/clockssleep-02-00022-g001.png)
Clocks & Sleep | Free Full-Text | MicroRNA: A Key Player for the Interplay of Circadian Rhythm Abnormalities, Sleep Disorders and Neurodegenerative Diseases
![A critical evaluation of pyrrolo[2,3- d ]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors - MedChemComm (RSC Publishing) DOI:10.1039/C4MD00090K A critical evaluation of pyrrolo[2,3- d ]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors - MedChemComm (RSC Publishing) DOI:10.1039/C4MD00090K](https://pubs.rsc.org/image/article/2014/MD/c4md00090k/c4md00090k-f3_hi-res.gif)
A critical evaluation of pyrrolo[2,3- d ]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors - MedChemComm (RSC Publishing) DOI:10.1039/C4MD00090K
![A critical evaluation of pyrrolo[2,3- d ]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors - MedChemComm (RSC Publishing) DOI:10.1039/C4MD00090K A critical evaluation of pyrrolo[2,3- d ]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors - MedChemComm (RSC Publishing) DOI:10.1039/C4MD00090K](https://pubs.rsc.org/image/article/2014/MD/c4md00090k/c4md00090k-f1_hi-res.gif)
A critical evaluation of pyrrolo[2,3- d ]pyrimidine-4-amines as Plasmodium falciparum apical membrane antigen 1 (AMA1) inhibitors - MedChemComm (RSC Publishing) DOI:10.1039/C4MD00090K
![IJMS | Free Full-Text | Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment IJMS | Free Full-Text | Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment](https://www.mdpi.com/ijms/ijms-22-11112/article_deploy/html/images/ijms-22-11112-g001.png)